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Japanese encephalitis (JE), a vector-borne viral dis-
ease, is endemic to large parts of Asia and the Paciﬁ  c. An 
estimated 3 billion people are at risk, and JE has recently 
spread to new territories. Vaccination programs, increased 
living standards, and mechanization of agriculture are key 
factors in the decline in the incidence of this disease in Ja-
pan and South Korea. However, transmission of JE is likely 
to increase in Bangladesh, Cambodia, Indonesia, Laos, 
Myanmar, North Korea, and Pakistan because of popula-
tion growth, intensiﬁ   ed rice farming, pig rearing, and the 
lack of vaccination programs and surveillance. On a global 
scale, however, the incidence of JE may decline as a result 
of large-scale vaccination programs implemented in China 
and India.
J
apanese encephalitis (JE) is a vector-borne viral disease 
that occurs in South Asia, Southeast Asia, East Asia, 
and the Paciﬁ  c (1). An estimated 3 billion persons live in 
countries where the JE virus is endemic (2), and the annual 
incidence of the disease is 30,000–50,000 cases (1). The 
disease can cause irreversible neurologic damage. The JE 
virus (JEV) is mainly transmitted by the mosquito Culex 
tritaeniorrhynchus, which prefers to breed in irrigated rice 
paddies. This mosquito species and members of the Cx. 
gelidus complex are zoophilic. Wading ardeid water birds 
(e.g., herons and egrets) serve as virus reservoirs, but the 
virus regularly spills over into pigs, members of the fam-
ily of equidae (e.g., horses and donkeys), and humans. The 
annual number of human deaths is 10,000–15,000, and the 
estimated global impact from JE in 2002 was 709,000 dis-
ability-adjusted life years (DALYs) (1,3). However, these 
statistics should be interpreted with care because the trans-
mission of JE is highly dynamic; hence, the disease usually 
occurs in epidemics, and there is considerable ﬂ  uctuation in 
estimates of its global impact. In 1999, JE caused 1,046,000 
DALYs; in the 2 subsequent years, it caused 426,000, and 
767,000 DALYs, respectively (3). Underlying factors that 
might explain these ﬂ  uctuations are contextual determi-
nants (mainly environmental factors) and spillover effects 
into the human population, which trigger epidemics.
Reporting of JE cases depends on the quality of health 
information systems and the ability to clinically and sero-
logically diagnose the disease. JE is often confused with 
other forms of encephalitis. Differential diagnosis should 
therefore include other encephalitides (e.g., conditions 
caused by other arboviruses and herpesviruses) and infec-
tions that involve the central nervous system (e.g., bacterial 
meningitis, tuberculosis, and cerebral malaria) (4).
Figure 1 shows the transmission of JE and highlights 
contextual determinants. Because infected pigs act as am-
plifying hosts, domestic pig rearing is an important risk fac-
tor in the transmission to humans (1). Two distinct epide-
miologic patterns of JE have been described. In temperate 
zones, such as the northern part of the Korean peninsula, 
Japan, China, Nepal, and northern India, large epidemics 
occur in the summer months; in tropical areas of south-
ern Vietnam, southern Thailand, Indonesia, Malaysia, the 
Philippines, and Sri Lanka, cases occur more sporadically 
and peaks are usually observed during the rainy season 
(5). Thus far, the reasons for the spread of JE are not fully 
understood. Bird migration might play a role in dispers-
ing JEV (6). Accidental transportation of vectors, human 
migration, and international travel seem to be of little im-
portance because viremia in humans is usually low and of 
short duration and because humans are dead-end hosts (1). 
JE was likely introduced into northern Australia by wind-
blown mosquitoes from Papua New Guinea (7) (Figure 1).
The main pillar of JE control is the use of a live at-
tenuated vaccine for humans, which was developed some 
40 years ago (8). Currently available JE vaccines are rela-
tively safe and effective, but a drawback is that multiple 
doses are required (1,9). Effective delivery of the vaccines 
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to poor, rural communities therefore remains a formidable 
challenge, and compliance and delivery costs have to be 
considered (10). Two vaccine candidates are in late-stage 
clinical development. The ﬁ  rst one is a second-generation, 
live inactivated, single-dose vaccine grown in Vero cells. It 
is the yellow fever virus–based chimeric vaccine and will 
soon enter the market (1). The second candidate is an atten-
uated SA 14–14–2 virus strain, adjuvanted with aluminum 
hydroxide and also grown in Vero cells (9,11).
The vaccination of pigs represents another potential 
strategy to control JE, but it is not widely used for 2 main 
reasons. First, the high turnover in pig populations would 
require annual vaccination of newborn pigs, which would 
be costly. Second, the effectiveness of live attenuated vac-
cines is decreased in young pigs because of maternal anti-
bodies (12).
Environmental management for vector control, such as 
alternative wetting and drying of rice ﬁ  elds (also known 
as intermittent irrigation), can substantially reduce vector 
breeding while saving water, increasing rice yields, and 
reducing methane emission (13). However, an effective 
irrigation requires well-organized educational programs, 
sufﬁ  cient water at speciﬁ  c times during the rice-growing 
cycle, and an adequate infrastructure. In addition, because 
vectors are largely dispersed, intermittent irrigation should 
be applied to all rice ﬁ  elds over large areas and during the 
entire cropping season, which is often not feasible (14). En-
vironmental management measures are most viable if they 
are readily integrated into a broader approach of pest man-
agement and vector management (15).
Chemical control of vector populations with insecti-
cides such as pyrethroids, organophosphates, and carbam-
ates plays a marginal role in JE control. In some circum-
stances (for example, when an outbreak of JE occurs in a 
densely populated area), space spraying can break the trans-
mission cycle in the short term. However, rising levels of 
insecticide resistance have compromised the effectiveness 
of this emergency measure. Indeed, JE vectors that prefer 
manmade habitats, such as irrigated rice ﬁ  elds, are often 
heavily exposed to pesticide selection pressure. Although 
JE vectors are prone to develop insecticide resistance, usu-
ally this issue arises with insecticides that are not directly 
targeted to JE control, but rather are targeted to control of 
other pests (16).
We provide a historic account of the origin of JE and 
disease epidemics, describe the current situation, and dis-
cuss several factors that might explain the rise of JE inci-
dence in some countries and its decline in others. Finally, 
we speculate about possible future trends.
Historic Account
Genetic studies suggest that JEV originated from an 
ancestral virus in the area of the Malay Archipelago. The 
virus evolved, probably several thousand years ago, into 
different genotypes (I–IV) and spread across Asia (17).
The history of the clinical recognition and recording of 
JE dates to the 19th century. JE appeared as recurring en-
cephalitis outbreaks in the summer season. The ﬁ  rst clinical 
case of JE was recorded in 1871 in Japan. Half a century 
later, also in Japan, a large JE outbreak involving >6,000 
cases was documented. Subsequent outbreaks occurred in 
1927, 1934, and 1935. In 1924 an agent from human brain 
tissue was isolated; 10 years later, it was proven to be JEV 
by transfection into monkey brains. The role of Cx. tritaenio-
rhynchus as a vector and the involvement of wading ardeids 
and pigs as reservoir hosts were demonstrated in 1938 (18).
Table 1 shows when the ﬁ  rst JE cases were described 
in countries currently considered JE-endemic. On the Ko-
rean Peninsula, the ﬁ  rst JE cases were recorded in 1933. On 
the Chinese Mainland, the ﬁ  rst JE cases were documented 
in 1940. In the Philippines, ﬁ  rst reports of JE cases occurred 
in the early 1950s (19). Eventually, the JE epidemic reached 
Pakistan (1983) as the furthest extension in the West, and 
Papua New Guinea (1995) and northern Australia (Torres 
Straight) as the furthest south. In parts of southeastern Russia 
(Primorje Promorsij), a few JE cases have been reported oc-
casionally (e.g., 2 cases from 1986 to 1990) (18). JE is poten-
tially endemic to Afghanistan, Bhutan, Brunei Darussalam, 
and the Maldives, but to our knowledge, no cases have been 
reported in these countries in the past 30 years. According 
to the World Health Organization (WHO), JE is endemic to 
the Western Paciﬁ  c Islands, but cases are rare (20). The en-
zootic cycle on those Paciﬁ  c Islands might not sustain viral 
transmission; hence, epidemics occur only after introduction 
of virus from JE-endemic areas. Subtle changes in the spa-
tiotemporal distribution of JEV are difﬁ  cult to track; thus, 
the year when a ﬁ  rst case of JE in a country is reported does 
not necessarily correspond with the actual ﬁ  rst occurrence of 
JE in that country (Table 1) (21–35).
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Figure 1. Contextual determinants and transmission of Japanese 
encephalitis.Japanese Encephalitis
Present Situation
Nearly half of the human population currently lives 
in countries where JEV occurs. As shown in Figure 2, JE 
is concentrated in China, India, and the Southeast Asian 
peninsula.
Current epidemiologic data on JE are summarized 
in Table 1. These data were gathered from a diversity of 
sources, including peer-reviewed literature, specialized 
text books, and reports from national health departments 
and international organizations, such as WHO and the 
Food and Agriculture Organization. We also contacted 
national health ministries and WHO country ofﬁ  ces for 
up-to-date information regarding country-speciﬁ  c JE sta-
tistics. This was accomplished by administering a stan-
dardized questionnaire.
There are 2 distinct trends in JE incidence. In countries 
such as Bangladesh, Cambodia, India, and Laos, where no 
speciﬁ  c diagnostic centers, vaccination programs, and sur-
veillance systems are in place, the incidence of JE appears 
to have increased in recent years. On the contrary, in China, 
Japan, Nepal, South Korea, Sri Lanka, and Thailand, where 
vaccination programs are being implemented and regular 
surveillance is pursued, the incidence of JE is stable or 
declining. Despite the availability of WHO estimates, the 
situation in North Korea, Myanmar, Pakistan, and Papua 
New Guinea remains largely unknown.
However, underreporting is substantial in most JE-
endemic countries; hence, it is conceivable that annual JE 
incidence is considerably higher than heretofore reported. 
For example, an estimate that used a representative inci-
dence of 25/10,000 (not immunized), and a 1994 popula-
tion estimate of 700 million children <15 years of age who 
live in JE-endemic areas suggested 175,000 cases annually 
with 43,750 deaths, and 78,750 cases with lasting seque-
lae. Adjusted for vaccine coverage, the estimate is 125,000 
cases per year (36).
Emerging JE
The emergence of JE can probably be explained by 
2 factors. First, JE-endemic countries experienced an un-
precedented population growth in recent decades. For ex-
ample, in Eastern Asia, South-Central Asia, and Southeast 
Asia, the population more than doubled, from 1.7 billion 
in the mid-1950s to 3.5 billion 50 years later (2). Second, 
pig rearing has grown exponentially and rice-production 
systems, particularly irrigated rice farming, have increased 
both in cropping area and cropping intensity. In China, 
for example, pork production doubled from 1990 to 2005. 
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Australia 1995 NA§ <1 <1¶ Stable Yes Yes (21)
Bangladesh 1977 106,385,000 (75)  NA 24,000 Increasing No No (22)
Cambodia 1965# 11,293,000 (80)  NA 4,000 Increasing No NA (23)
China 1940 422,532,000 (32) 8,000–10,000 281,000 Decreasing Yes  Yes  (18)
India 1955 597,542,000 (54) 1,500–4,000 226,000 Increasing No Yes  (24)
Indonesia 1960 116,114,000 (52)  NA 23,000 Increasing No NA (25)
Japan 1924 43,969,000 (34) <10** <1 Stable Yes Yes (26)
North Korea  1933 8,606,000 (38)  NA 6,000 NA NA NA (27)
South Korea  1933 9,194,000 (19)  <20 6,000 Stable Yes  Yes  (27)
Laos 1989 4,643,000 (78) NA 5,000 Increasing No Yes (28)
Malaysia 1952†† 8,854,000  (35)  50–100 2,000 Decreasing Yes  Yes  (29)
Myanmar 1965 35,077,000  (69)  NA 13,000 Increasing No NA (18)
Nepal 1978 4,567,000 (20) 1,000–3,000 5,000 Stable Yes Yes (30)
Papua New 
Guinea
1995 5,109,000 (87)  NA 2,000 NA NA NA (21)
Pakistan 1983 18,536,000 (12) NA 82,000 Increasing NA NA (27)
The Philippines  1950 31,081,000 (37)  10–50 8,000 Stable No Yes  (19)
Singapore 1952 0 <1 260 Stable No Yes (31)
Sri Lanka  1968 16,381,000 (79)  100–200 1,000 Decreasing Yes  Yes  (32)
Thailand 1964 43,364,000 (68) 1,500–2,500 5,000 Decreasing Yes Yes  (18,27)
Vietnam 1960 61,729,000 (73) 1,000–3,000 11,000 Stable Yes Yes  (27,33)
*Japanese encephalitis (JE)–-endemic areas drawn from map provided in (34); rural population estimates derived from United Nations Urbanization 
Revisions (2). 
†Information retrieved from questionnaires answered by employees from Ministry of Health and World Health Organization country offices. 
‡Estimates for 2002 from World Health Organization (20). DALYs, disability-adjusted life years. 
§<1% of the country is JE-endemic (Torres Straight islands, Cape York Peninsula). NA, not available. 
¶Two deaths since 1995 (35).
#Virus isolated from mosquito (29). 
**JE cases are very rare; highest risk is on Okinawa, Miyako, and Ishigaki islands. Between 1995 and 2005, 3 cases were reported (all in 2002) (26). 
††First isolated from humans. During World War II, an outbreak that was probably due to JE occurred (31).PERSPECTIVES
Today, the total rice-harvested area of all JE-endemic 
countries (excluding the Russian Federation and Australia) 
is 1,345,000 km2, an increase of 22% in the past 40 years. 
Over the same time span, the total rice production in these 
countries has risen from 226 million tons to 529 million 
tons (+134%) (37).
Table 2 presents information on 3 key environmen-
tal contextual determinants of JE transmission, stratiﬁ  ed 
by country. The following issues are offered for consid-
eration. First, the number of people living in close prox-
imity to irrigated areas reﬂ  ects the fraction of the popu-
lation that potentially is at an elevated risk of acquiring 
JE. Methods for calculating those numbers have been 
described elsewhere (13). Second, the absolute and rela-
tive change of irrigated rice area and, third, the relative 
change in pork production can be used as proxies for al-
terations in the risk of acquiring JE. In absolute numbers 
(116.6 million) and in relative terms, most people living 
in close proximity to irrigated areas are from Bangladesh 
(82%); the second largest population lives in India (107.8 
million), followed by China (22.0 million). The largest 
irrigated rice area in 2005 was found in India (41.9 mil-
lion ha), followed by China (29.0 million ha), Bangladesh 
(10.5 million ha), and Thailand (10.0 million ha). Highest 
increases in irrigated rice areas in the past 15 years were 
estimated for Myanmar (+47%) and Cambodia (+30%). 
Highest increases in pork production occurred in Myan-
mar (+381%), Vietnam (+147%), and China (+87%). On 
the other hand, pork production declined in Malaysia 
(–47%), North Korea (–35%), and Japan (–23%).
Despite the fact that irrigated rice production and pig 
rearing are key factors in the transmission of JE, crude 
numbers fail to completely explain the complex interplay 
of various contextual determinants of the disease. Clearly, 
where rice production and pig rearing overlap, the impact 
on JE transmission is stronger than in areas where both ac-
tivities are physically separated. This is the case, for ex-
ample, in Malaysia, where the Malays mainly grow rice in 
1 area and the Chinese rear pigs in another area. Here, the 
social determinant of religion (most Malays are Muslim) 
plays a decisive factor (Table 2).
Conclusion and Outlook
Discovered 125 years ago, JE has spread widely in the 
20th century. Almost half of the human population now 
lives in countries where the disease is endemic. JE is a 
vector-borne epidemic with several features that are typi-
cal of an emerging infectious disease. The failure to halt 
the spread of JE in Asia and the Paciﬁ  c region, despite the 
availability of an effective and inexpensive vaccine for 40 
years, is of considerable public health concern. A similar 
conclusion has been drawn for yellow fever, a disease that 
can also be prevented by vaccination yet is rampant (38). 
Similar to schistosomiasis, malaria, food-borne tremato-
diasis, lymphatic ﬁ  lariasis, and dengue, one of the main 
reasons for the proliferation of JE is the ecologic transfor-
mation caused by water resources development and man-
agement that create suitable breeding sites for vectors and 
intermediate hosts, which in turn inﬂ  uence the frequency 
and transmission dynamics of these diseases (39).
High-quality data on transmission and incidence of 
JE are lacking in various countries. Although clinical and 
serologic methods to diagnose and monitor JE are avail-
able, health systems in many developing countries are un-
able to differentiate encephalitis diagnoses. Information 
regarding the distribution and public health importance 
of JE in Bangladesh, Cambodia, Indonesia, North Korea, 
Laos, Myanmar, Papua New Guinea, and Pakistan is in-
adequate. Such epidemiologic information, however, is 
mandatory for advocacy and allocation of resources for 
the control of JE. Examples of countries with successful 
JE control programs are Japan and South Korea. Before 
the 1950s, these countries experienced JE outbreaks, but 
incidence rates have remained stable for >2 decades. The 
following key control strategies and developments might 
explain the successful decline of JE in these countries: 
1) large-scale immunization programs for humans, 2) pig 
immunization and the separation of pig rearing from hu-
man settlements, 3) changes in agricultural practices (e.g., 
enhanced mechanization and decrease of irrigated land), 
and 4) improved living standards (e.g., better housing and 
urbanization).
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Figure 2. Disability-adjusted life years (DALYs) per 100,000 
persons in Japanese encephalitis–endemic countries. Numbers in 
parentheses indicate estimated number of deaths in 2002 according 
to the World Health Organization (20). NA, not available. Japanese Encephalitis
We speculate that JE incidence is increasing mainly 
in low-income countries. However, because reliable ﬁ  gures 
about JE emergence are lacking due to the absence of rigor-
ous monitoring systems, more research is needed to support 
or refute this claim. In any event, lack of political will and 
ﬁ  nancial resources are 2 important reasons why JE is often 
given low priority. These factors might explain the paucity 
of JE immunization programs for children in low-income 
countries where the disease is endemic. Nevertheless, Sri 
Lanka and Nepal, 2 countries with limited health budgets, 
and Thailand and Vietnam have managed to successfully 
control JE.
The national situations with respect to JE in the near 
future could develop as follows. We hypothesize that in 
Cambodia, Laos, and Myanmar, severe JE outbreaks could 
occur in the near future, partially explained by increases 
in irrigated rice farming and enhanced pig rearing. The JE 
situation in North Korea is not well understood, but on the 
basis of the population’s general health status, we predict 
that JE will likely remain a substantial public health issue 
in the years to come. Bangladesh and Pakistan are among 
the worst affected and most populous countries in which 
JE is endemic, and yet effective surveillance is missing. 
Outbreaks are likely to occur but will remain largely un-
detected. Muslim countries such as Bangladesh and Paki-
stan have traditionally been JE free. JEV transmission ends 
in Pakistan, even though the JE vector is abundant further 
to the West. The recent rise in JE in those countries has 
yet to be fully investigated and shows the complexity of 
transmission of this disease. In Indonesia, Malaysia, the 
Philippines, and Singapore, JE incidence has usually been 
low, and transmission will remain stable at a relatively low 
level. Given the paucity of data in Indonesia, a monitor-
ing system should be established to document changes over 
time. Occasional small JE outbreaks might also occur in 
Papua New Guinea with spillover to Australia. Awareness 
of the disease and vaccination coverage rates are high in 
Australia, particularly in the region of the Torres Strait; 
hence, it seems unlikely that larger epidemics will occur 
anytime soon.
The overall trend of JE has been declining over the past 
3 decades, and we anticipate that this trend will continue in 
the long term. Indeed, China and India inﬂ  uence JE ﬁ  gures 
on a global scale because most people living in JE-endemic 
areas are concentrated in these 2 countries. The incidence 
of JE in China has declined since 1971, coincident with 
economic growth and development. Meanwhile, the na-
tional JE vaccination program has been integrated into the 
Expanded Program on Immunization, and, at present, >110 
million doses of a live, attenuated vaccine (SA14–14–2 
strain) are produced annually. However, social, economic, 
and health policy changes in the face of privatization and a 
more market-based economy have led to reduced funding 
for immunization programs and somewhat reduced salaries 
for public health workers, particularly in the poorest prov-
inces. As a consequence, these changes have contributed 
to increasing disparities in immunization coverage rates 
between the wealthy coastal and the less developed rural 
provinces and thus to the recently observed differences in 
levels of JE incidence between those regions (40).
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Table 2. Rice irrigation and pork production by Japanese encephalitis–endemic country, 1990 and 2005* 
Country 
Persons in close proximity to 
rice irrigation† 




% Change in 
paddy area 
% Change in pork 
production†
Australia NA NA NA NA NA
Bangladesh 116,600,000 10,435 10,524 +1 NA
Cambodia 1,426,000 1,855 2,415 +30 +46
China 22,019,000 33,519 29,087 –13 +87
India 107,785,000 42,687 41,907 –2 –8
Indonesia 7,169,000 10,502 11,802 +12 –13
Japan 1,947,000 2,074 1,706 –18 –23
North Korea  414,000 600 590 –2 –35
South Korea  921,000 1,244 980 –21 +69
Laos 164,000 NA NA NA +21
Malaysia 181,000 681 676 –1 –47
Myanmar 3,120,000 4,760 7,008 +47 +381
Nepal 554,000 1,455 1,542 +6 +12
Papua New Guinea  110 NA NA NA NA
Pakistan 513,000 2,113 2,621 +24 NA
The Philippines  12,200,000 3,319 4,200 +27 +18
Singapore 0 0 0 0 NA
Sri Lanka  2,232,000 828 915 +10 +21
Thailand 8,330,000 8,792 10,042 +14 +80
Vietnam 18,648,000 6,043 7,329 +21 +147
*NA, not available. 
†Sources of data and method of calculation are described by Keiser et al. (13).
‡Source: Food and Agriculture Organization (37).PERSPECTIVES
The incidence of JE in India is still increasing, and the 
case-fatality rate of reported cases is high, i.e., 10%–30% 
(online Technical Appendix, supplementary reference 41; 
available from www.cdc.gov/EID/content/15/1/1-Techapp.
pdf). India currently has no national vaccination program, 
but the Ministry of Health has recently drawn up a plan in 
which children 1–12 years of age will be immunized. In 
Tamil Nadu and Uttar Pradesh, immunization programs are 
already running; thus, JE incidence might stabilize in those 
regions. However, overall trends for India are difﬁ  cult to 
predict because JE endemicity is heterogeneous and be-
cause socioeconomic conditions for control differ substan-
tially from 1 state to another (online Technical Appendix, 
supplementary reference 42).
Coverage of immunization programs and changes in 
agricultural practices will further inﬂ  uence JE transmis-
sion. In Taiwan, for example, the average age for the onset 
of conﬁ  rmed JE cases shifted from children <10 years to-
ward adulthood, explained by a high coverage of vaccinated 
children (online Technical Appendix, supplementary refer-
ence 43). Interestingly, the peak JE transmission, which 
occurred in August in the 1960s, shifted to June beginning 
in the 1980s. Improvements in pig-feeding technologies, 
which resulted in shorter periods from birth to pregnancy 
of female pigs, has been proposed as an important reason 
explaining the shift in transmission (online Technical Ap-
pendix, supplementary reference 44).
Climate change has been implicated in the increase 
of transmission of several vector-borne diseases (online 
Technical Appendix, supplementary reference 45). For 
example, a potential effect of climate change has been 
shown empirically for dengue virus, which is closely re-
lated to that of JE (online Technical Appendix, supple-
mentary reference 46). Although JE vector proliferation 
might be inﬂ  uenced in a similar way than that predicted 
for dengue vectors, the potential impact of climate change 
on JE remains to be investigated. Indeed, climate change 
could not only directly increase JE vector proliferation 
and longevity but could also indirectly increase disease 
because of changing patterns of agricultural practices such 
as irrigation (online Technical Appendix, supplementary 
references  47,48). Areas with irrigated rice-production 
systems may become more arid in the future, and the 
impact of ﬂ  ooding will be more dramatic, which in turn 
might result in JE outbreaks. Generally, extreme rainfall 
after a period of drought can trigger outbreaks in situa-
tions in which vector populations rapidly proliferate and 
blood feeding is spilling over to humans. Climate change 
may also inﬂ  uence migration patterns of birds, which may 
result in JEVs being introduced into new areas. However, 
little is known about reservoir bird migration patterns; 
hence, this issue remains to be investigated (6).
The culicines that transmit JE are usually highly zoo-
philic, and human outbreaks are therefore the result of a spill-
over of the virus from the animal reservoir into the human 
population. Studies in Sri Lanka showed that spillovers hap-
pen when there is rapid and dramatic buildup of Culex spp. 
populations to the extent that the number of human blood 
meals passes a threshold after which virus transmission be-
gins (online Technical Appendix, supplementary reference 
49). Such rapid buildups are a result of extreme weather 
conditions or of rice ﬁ  elds in semi-arid areas being ﬂ  ooded 
before rice is transplanted. Information on vector population 
dynamics would be very useful in early warning systems and 
could also help improve targeting of control programs.
In conclusion, JE can be controlled, with effective sur-
veillance systems and vaccines playing key roles. Although 
currently available vaccines are effective, the need for 3–4 
injections compromises compliance and increases delivery 
costs (10). The advent of second-generation, cell-culture–
derived vaccines will continuously replace mouse-brain 
and hamster kidney cell–derived vaccines. Such develop-
ments will hopefully boost current vaccination programs 
and deliver safer, more efﬁ  cacious, and cheaper vaccines 
that comply with regulatory norms. Political will and com-
mitment,  ﬁ   nancial resources, intersectoral collaboration 
(between the Ministries of Health and Agriculture and oth-
er stakeholders to set up vaccination programs for young 
children), as well as changing agricultural practices, pig 
vaccination, rigorous monitoring, and surveillance will go 
a long way in controlling JE.
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